Lemaitre Vascular (LMAT) Shares Outstanding (Diluted Average) (2010 - 2025)

Lemaitre Vascular (LMAT) has 15 years of Shares Outstanding (Diluted Average) data on file, last reported at $22.9 million in Q2 2025.

• Shares Outstanding (Diluted Average) for Q2 2025 came in at $22.9 million, up 1.05% year-over-year; the trailing twelve-month figure through Jun 2025 was $22.9 million (up 1.05% YoY), and the FY2024 annual result was $22.8 million, up 1.59% from the prior year.
• Shares Outstanding (Diluted Average) steadied at $22.9 million in Q2 2025 per LMAT's latest filing, from $22.9 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $22.9 million in Q1 2025 and troughed at $163000.0 in Q1 2023.
• A 5-year average of $17.3 million and a median of $22.2 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) sank 99.26% in 2023, then surged 13746.63% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $21.5 million in 2021, then rose by 3.24% to $22.2 million in 2022, then gained by 1.14% to $22.4 million in 2023, then advanced by 1.59% to $22.8 million in 2024, then rose by 0.51% to $22.9 million in 2025.
• Business Quant data shows LMAT's Shares Outstanding (Diluted Average) at $22.9 million in Q2 2025, $22.9 million in Q1 2025, and $22.8 million in Q4 2024.